ACQUISITION OF MEDICINE SEMAGLUTIDE APPROVED BY ISP FOR USE IN OBESITY FOR OBESITY APPROACH STRATEGY MANAGED FROM THE S.S.O.

By: OSORNO HEALTH SERVICE๐Ÿ“ ChileOpen

Key Information

ReferenceGB-1057532-108-LE26
DeadlineNov 16, 2026 12:00 AM
Estimated ValueCLP 43,676,000.00
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryChile
PublishedNov 4, 2026

Description

The Service in this tender requires implementing the Obesity Approach strategy, which contemplates the delivery of Semaglutide medication in 4 injectable presentations approved by the ISP for use in O...

Full details are available after unlocking this tender.